# Greenwood Way Capital

> Greenwood Way Capital is a VC fund backing Energy, Software and Web Apps. See 6 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 6
- Last investment: Feb 2022
- Lead investor: 67%
- Last updated: Aug 2026
- Website: https://www.gwc.london/

Greenwood Way Capital is a VC fund focused on Energy and Software. Greenwood Way Capital offers their members, both funds and individuals, the opportunity to co-invest in early stage companies. The investment opportunities are usually selected by our partner syndicates and are usually early-stage UK companies which have innovative ideas or unique disruptive technologies and are led by highly entrepreneurialmanagement.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Energy | 1 | 17% |
| Software | 1 | 17% |
| Web Apps | 1 | 17% |
| Electronics | 1 | 17% |
| Life Science | 1 | 17% |

16 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Venture - Series Unknown | 2 | 33% |
| Seed | 1 | 17% |
| Series A | 1 | 17% |
| Funding Round | 1 | 17% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Power Roll | Power Roll Limited was established to develop and commercialise its highly innovative proprietary energy storage and energy generation technologies. Power Roll technologies exhibit a range of significant benefits and advantages over existing technologies such that it is likely that the technology can prove extremely disruptive across a wide rangeof applications and markets. Power Roll has a strong intellectual property portfolio, with 15 different patent families already established. These patent families are spread across all three technologies with five directly related to Energy Storage, nine related to Solar PV and one focusing on the nano-barrier technology. | $8.1M | Venture - Series Unknown | Feb 07, 2022 |  |
| epipole | Epipole are a UK-based retinal imaging company. Epipole was founded in January 2011 with the express aim of building intellectual property in the application areas of image processing, 3D and medical imaging. We have developed the epiCam family of retinal video devices, which launched in 2016. They are now disrupting the ophthalmic device space andintroducing clinicians to entirely new ways of working and understanding retinal imagery - and in some cases helping to generate entirely new science. The epiCam V veterinary variant was launched in 2017, enabling high quality fundus imaging of a variety of animals. | $1.8M | Venture - Series Unknown | Jan 20, 2022 |  |
| Landytech | Landytech is a software company that develops next-generation software platforms for investment reporting and risk analytics for family offices, asset managers, and fiduciaries. It also offers to empower the modern investor with automated investment reporting, risk management, and data aggregation. | $6M | Series A | Nov 10, 2021 |  |
| ETA GREEN POWER LTD | ETA's patented technology delivers advanced electric motors, power controllers and inverters to the Outdoor power equipment, Off highway, e-mobility, marine and HVAC sectors.Developed from over 15 years of research and expertise, our technology answers the unmet need for a market leading, efficient and inexpensive electric drive systemalternative to traditional internal combustion engines and some existing electric motors.Our game-changing electric motor topology offers advanced efficiency, high performance and a cost effective solution removing reliance on hydrocarbon fuel sources and rare-earth magnets whilst minimising manufacturing processes. |  | Seed | Sep 01, 2020 |  |
| epipole | Epipole are a UK-based retinal imaging company. Epipole was founded in January 2011 with the express aim of building intellectual property in the application areas of image processing, 3D and medical imaging. We have developed the epiCam family of retinal video devices, which launched in 2016. They are now disrupting the ophthalmic device space andintroducing clinicians to entirely new ways of working and understanding retinal imagery - and in some cases helping to generate entirely new science. The epiCam V veterinary variant was launched in 2017, enabling high quality fundus imaging of a variety of animals. | $1.9M | Venture - Series Unknown | Jun 24, 2020 |  |
| Sphere Bio | Sphere Fluidics Limited is a new Life Sciences company which has developed unique products for use in single cell analysis and characterisation and provides collaborative R&D services in this area. | $4.8M |  | Jun 10, 2019 |  |

6 of 6 investments shown.

## Co-investors
- [24 Haymarket](https://shizune.co/investors/profile/24-haymarket) — VC Fund, 1 deal together
- [Adelie](https://shizune.co/investors/profile/adelie-afcc) — VC Fund, 1 deal together
- Armajaro Asset Management — VC Fund, 1 deal together
- [Oxford Investment Consultants LLP](https://shizune.co/investors/profile/oxford-technology-and-innovations-fund) — VC Fund, 1 deal together
- [RAB Capital](https://shizune.co/investors/profile/rab-capital) — VC Fund, 1 deal together
- [Scottish Enterprise](https://shizune.co/investors/profile/scottish-enterprise) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Bossa Invest](https://shizune.co/investors/profile/bossanova-investimentos) — VC Fund
- [Almi Invest](https://shizune.co/investors/profile/almi-invest) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund

## FAQ

### What does Greenwood Way Capital invest in?

Greenwood Way Capital invests primarily in Energy, Software and Web Apps startups, most often at Venture - Series Unknown and Seed stage. Most of the 6 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Greenwood Way Capital last invest?

The most recent investment recorded for Greenwood Way Capital closed in Feb 2022. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co